If you can reliably reduce costs for healthcare facilities, you're going to be quite popular. To that end, Healthcare Services Group (Nasdaq:HCSG) has indeed built a very appealing and scalable business in providing housekeeping, linen/laundry and dining services to healthcare facilities. While this company has a pretty compelling dividend story, the valuation is a bit confounding.

SEE: Countries With The Highest Healthcare Spending.

Cost Challenges Bite into First Quarter Results
Although Healthcare Services did well on the top line, cost control proved to be a more challenging situation. Revenue rose 25%, as the company continues to see solid performance in its core housekeeping/laundry services, but also impressive growth from dietary services, as more clients add these services.

Part of the profitability issue, then, is amortizing the cost of the growing dietary business. The company has to make certain commitments in terms of management infrastructure to roll out this business, but there is a lag in building up enough customers to absorb that overhead.

Consequently, the company's cost of services rose 26%, dropping gross margin nearly a point. Operating income was up just 4%, as that increased cost of services chewed up incremental profitability.

SEE: What Health Insurance Covers.

A Wall Street Love Story?
Although the company's profits were well below sell-side expectations (though few analysts follow this stock), the Street doesn't seem to care. Investors seem sold on the idea that Healthcare Services needs time to build the dietary business, but once it reaches critical mass the profit growth will be significant.

Certainly there is an appealing growth angle to this company. HCSG already provides housekeeping and laundry services to about 2,900 facilities, with 600 of them also using the company's dietary services (nearly doubling in the past year). Lest you think HCSG is close to market saturation, remember that there are nearly 7,000 hospitals in North America and more than 23,000 nursing homes, long-term care facilities and other potential customers.

A Good Model, but Could It Be Better?
Healthcare Services runs an admittedly appealing model - essentially taking over the management of the facility's housekeeping, laundry and dietary needs. The company largely uses the existing infrastructure in place and indexes its labor costs to the costs of the facility's other unskilled workers. Consequently, this is a business where the company can earn a fairly predictable margin without large capital commitments.

I wonder if the model can get even better. Now, there's nothing wrong with the housekeeping model and it works along similar lines as Ecolab (NYSE:ECL) (and Ecolab is a competitor in some healthcare settings). I do wonder about the laundry/linen service, though. While the company uses the facility's own equipment (or will install some in certain cases), could there be better cost leverage from an outsourced, centralized model like that used by Cintas (Nasdaq:CTAS) or Aramark?

The Bottom Line
One of the simultaneous challenges and opportunities for this company is the fact that companies like HCA (NYSE:HCA) and Kindred Healthcare (NYSE:KND) are actually a little unusual in the industry. A lot of the hospital industry and most of the nursing home industry is still run by small "mom-and-pop" operators and that not only increases the service costs, but also makes them more vulnerable to ongoing cuts in Medicare and Medicaid reimbursement (if facilities take in less revenue, there's less available money for service providers like Healthcare Services).

Frankly I'm flummoxed by the valuation Healthcare Services Group gets. While the 35 straight quarters of dividend growth is indeed very laudable, even mid-teens compound free cash flow growth over the next decade isn't enough to come close to the current stock price. My fear, then, is that investors are paying too much for that dividend growth and the expectation that HCSG will profit from the graying of America.

SEE: Healthcare Funds: Give Your Portfolio A Booster Shot.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Stephen Simpson did not own shares in any of the companies mentioned in this article.
Related Articles
  1. Investing News

    Bank Stocks: Time to Buy or Avoid? (WFC, JPM, C)

    Bank stocks have been pounded. Is this the right time to buy or should they be avoided?
  2. Stock Analysis

    Why the Bullish Are Turning Bearish

    Banks are reducing their targets for the S&P 500 for 2016. Here's why.
  3. Stock Analysis

    How to Find Quality Stocks Amid the Wreckage

    Finding companies with good earnings and hitting on all cylinders in this environment, although possible, is not easy.
  4. Investing News

    What You Can Learn from Carl Icahn's Mistakes

    Carl Icahn has been a stellar performer in the investment world for decades, but following his lead these days could be dangerous.
  5. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  6. Investing

    What Investors Need to Know About Returns in 2016

    Last year wasn’t a great one for investors seeking solid returns, so here are three things we believe all investors need to know about returns in 2016.
  7. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  8. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  9. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  10. Stock Analysis

    The Top 5 Micro Cap Biotechnology Stocks for 2016 (BSTC, OSIR)

    Discover some of the most promising micro-cap biotechnology stocks that investors can consider for their 2016 investment portfolio.
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center